Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.90
+0.50 (+0.26%)
Official Closing Price
Updated: 4:10 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
65
66
Next >
Big Players' Recent Trades in ABBV Options
January 05, 2024
Via
Benzinga
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via
Investor's Business Daily
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
January 04, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
AbbVie Inc. (NYSE: ABBV) Highlighted for Surprising Price Action
January 02, 2024
Via
Investor Brand Network
Peering Into AbbVie's Recent Short Interest
December 29, 2023
Via
Benzinga
Market Whales and Their Recent Bets on ABBV Options
December 22, 2023
Via
Benzinga
1 Concerning Trend for AbbVie Investors to Keep an Eye On
January 03, 2024
Is AbbVie a good stock for dividend investors to own?
Via
The Motley Fool
3 Biotech Stocks Set for Breakthroughs in 2024
January 02, 2024
With groundbreaking advancements in new medicine and science, 2024 holds a promising future for these biotech stocks.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
Via
Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
January 02, 2024
The types of innovative drugs these companies develop are always in high demand.
Via
The Motley Fool
3 Top Dividend Growth Stocks to Buy in 2024
January 02, 2024
Income investors should love these great stocks.
Via
The Motley Fool
The 3 Hottest Dividend Stocks to Watch in 2024
January 01, 2024
With 2023 in the books and the entirety of 2024 ahead of us, here are compelling dividend stocks to watch for astute investors.
Via
InvestorPlace
AbbVie Inc. (NYSE: ABBV) Highlighted for Surprising Price Action
December 22, 2023
Via
Investor Brand Network
$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today
December 21, 2023
Via
Benzinga
8 Analysts Have This to Say About AbbVie
December 18, 2023
Via
Benzinga
3 Top ETFs I'm Planning to Buy Hand Over Fist in 2024, Despite All the Cheap Stocks on My Radar
January 01, 2024
I'm adding some ETFs to my retirement portfolio in 2024; here are the three I'm starting with.
Via
The Motley Fool
Topics
ETFs
Retirement
Exposures
Pension
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio
December 31, 2023
Getting going on investing is a terrific way to start 2024.
Via
The Motley Fool
4 Incredible Dividend Stocks Yielding 4%-Plus to Buy in 2024
December 31, 2023
These companies pay attractive dividends that should continue rising.
Via
The Motley Fool
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
Via
Benzinga
Better Income Stock: AT&T or AbbVie?
December 17, 2023
These two blue chips are highly prized for their top-shelf dividend programs.
Via
The Motley Fool
Common Investing Mistake: Income Obsession (& More)
December 28, 2023
A common investing mistake is income obsession. Others are holding too many stocks and focusing on valuation to know if the price of a stock is right. Sounds familiar? Any of these mistakes hurts your...
Via
Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
December 26, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Small Caps Are On A Tear Including Speculative Biotechs
December 26, 2023
So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation.
Via
Talk Markets
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
December 26, 2023
The acquisition fills an immediate need with some extras to boot.
Via
The Motley Fool
29 Undervalued Dividend Aristocrats: December 2023
December 25, 2023
The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Better Growth Stock: AbbVie vs. Abbott Laboratories
December 21, 2023
Do Humira's declining sales give Abbott Laboratories the edge as the better growth stock?
Via
The Motley Fool
7 Blue-Chip Dividend Stocks to Buy Before Dec. 31
December 19, 2023
Always a strong investment, blue-chip dividend stocks continue to make sense as 2023 draws closer to an end and 2024 nears.
Via
InvestorPlace
7 ‘Bulletproof’ Stocks to Buy Ahead of a Wild New Year
December 19, 2023
If you don’t quite trust the hyper-bullish narrative, these ideas can help boost confidence.
Via
InvestorPlace
Stock(ing) Stuffers That Could Be Lovin The High 2024
December 18, 2023
Via
Talk Markets
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
December 18, 2023
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.
Via
Talk Markets
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
65
66
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.